MIR7975

Across TCGA pan-cancer cohorts, MIR7975 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR7975 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MIR7975 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR7975 expression acts as an unfavorable survival marker, although some lineages such as TGCT and GBM show a favorable association.

SKCM, COAD, and PAAD are the cancer types where MIR7975 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	II,III,IV	0.253	0.699	<.001	96	view →
COAD	OS	Tertile	III,IV	0.039	0.783	<.001	90	view →
PAAD	OS	Tertile	All	0.094	0.640	<.001	72	view →
MESO	OS	Tertile	III,IV	0.274	0.574	.021	36	view →
BRCA	OS	Tertile	IV	0.233	0.755	.038	36	view →
SARC	DFS	Tertile	All	0.136	0.598	.001	36	view →
TGCT	DFS	Quartile	All	0.980	0.775	.003	18	view →
BLCA	DFS	Tertile	IV	0.232	0.483	.049	9	view →
GBM	DFS	Tertile	All	1.000	0.204	.042	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR7975–SKCM (DFS)

Open the SKCM breakdown →